Institute of Medical Psychology, Greifswald University School of Medicine.
Department of Dermatology, Greifswald University School of Medicine.
J Dtsch Dermatol Ges. 2017 Aug;15(8):791-799. doi: 10.1111/ddg.13294.
Regular assessment of psychosocial distress is an important component of adequate psycho-oncological and social support in cancer patients. To date, relevant studies on skin cancer patients have primarily included individuals with melanoma.
(1) Does the need for psychosocial support vary with the type of skin cancer? (2) Do mentally distressed patients desire support? (3) From the various individuals in the treatment team, whom do patients choose as potential contact person?
Inpatients with skin cancer were asked to self-assess their psychosocial situation using the Hornheide questionnaire. In addition, they were asked about their desire for psychosocial support and the preferred potential contact person.
The need for support among the 116 patients surveyed varied significantly depending on the diagnosis (p = 0.007). However, the direct comparison between patients with melanoma (n = 38; 32.8 %) and squamous cell carcinoma (n = 9; 7.8 %) (p = 0.724) or other types of skin cancer (n = 20; 17.2 %) (p = 0.366) revealed no such difference. The prevalence of psychosocial distress (n = 49; 42.2 %) and the desire for support (n = 20; 17.4 %) showed considerable differences. Patients primarily chose a physician (n = 14/35) or a psychologist (n = 13/35) as potential "go-to" person for their mental distress.
Apart from psychosocial distress, the desire for support should be assessed, and patients should be provided access to additional psychosocial care options. With respect to the need for psychosocial support, it does not seem to be justified to preferentially - or even exclusively - consider melanoma patients in clinical practice and research.
定期评估心理社会困扰是癌症患者获得充分心理肿瘤学和社会支持的重要组成部分。迄今为止，有关皮肤癌患者的相关研究主要包括黑色素瘤患者。
（1）心理社会支持的需求是否因皮肤癌的类型而异？（2）心理困扰的患者是否需要支持？（3）在治疗团队的各种人员中，患者选择谁作为潜在的联系人？
皮肤癌住院患者使用霍恩海德问卷自行评估他们的心理社会状况。此外，他们还被问及对心理社会支持的需求以及首选的潜在联系人。
调查的 116 名患者的支持需求因诊断而异（p=0.007）。然而，黑色素瘤患者（n=38；32.8%）与鳞状细胞癌患者（n=9；7.8%）（p=0.724）或其他类型皮肤癌患者（n=20；17.2%）（p=0.366）之间的直接比较并没有显示出差异。心理社会困扰的患病率（n=49；42.2%）和支持需求（n=20；17.4%）存在较大差异。患者主要选择医生（n=14/35）或心理学家（n=13/35）作为解决其精神困扰的潜在“首选”人。
除心理社会困扰外，还应评估支持需求，并为患者提供更多心理社会护理选择。就心理社会支持的需求而言，在临床实践和研究中优先考虑（甚至完全考虑）黑色素瘤患者似乎没有道理。
